Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 7 Best ASX Stocks to Buy Now. On June 23, the company announced that the US FDA approved a label expansion for Illuccix® (kit for the ...

Bristol Myers Squibb (NYSE:BMY) announced that the U.S. FDA has approved several label updates for its cancer therapies, ...

for the treatment of primary vitreoretinal lymphoma (PVRL), a rare and potentially fatal cancer currently lacking US FDA-approved therapy. “Primary vitreoretinal lymphoma is treated today off label ...

The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...

FDA approved label changes for Breyanzi and Abecma, easing access by reducing monitoring rules and eliminating REMS safety ...

US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...

Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...

FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding ...

The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

The FDA has approved expanded use of GE HealthCare’s PET imaging agent, Vizamyl, for improved detection and monitoring of Alzheimer’s disease. The updated label now allows Vizamyl to be used to detect ...